Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trialHisham Mehanna, Mererid Evans|The Lancet|2018Cited by 1k
Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysisChristina Henson, Hisham Mehanna, Pierluigi Bonomo et al.|Frontiers in Oncology|2023Cited by 31
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scaleSusanne Singer, Eva Hammerlid, Iwona M. Tomaszewska et al.|Quality of Life Research|2021Cited by 17
Development and validation of an improved classification and risk stratification system for carotid body tumors: Multinational collaborative cohort studyHisham Mehanna, Daniele Borsetto, Pankaj Mistry et al.|Head & Neck|2021Cited by 7